Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Research Article
Nature Biotechnology  16, 1033 - 1039 (1998)
doi:10.1038/3473

Engraftable human neural stem cells respond to development cues, replace neurons, and express foreign genes

Jonathan D. Flax5, Sanjay Aurora5, Chunhua Yang, Clemence Simonin, Ann Marie Wills, Lori L. Billinghurst, Moncef Jendoubi1, Richard L. Sidman2, John H. Wolfe3, Seung U. Kim4 & Evan Y. Snyder

  Departments of Neurology, Pediatrics, and Neurosurgery, Children's Hospital, Harvard Medical School, Boston, MA.

1  National Eye Institute, National Institute of Health , Bethesda, MD.

2  New England Regional Primate Center, Harvard Medical School, Southborough, MA.

3  Department of Pathobiology and Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA.

4  Division of Neurology, Department of Medicine, University Hospital, University of British Columbia, Vancouver, BC, Canada.

5  These authors contributed equally to this work.

Correspondence should be addressed to Evan Y. Snyder Corresponding author (Snyder@A1.TCH.Harvard.edu ).
cell therapyprogenitor cellgene therapyTay-Sachs diseasetransplanationdifferentiation
Stable clones of neural stem cells (NSCs) have been isolated from the human fetal telencephalon. These self-renewing clones give rise to all fundamental neural lineages in vitro. Following transplantation into germinal zones of the newborn mouse brain they participate in aspects of normal development, including migration along established migratory pathways to disseminated central nervous system regions, differentiation into multiple developmentally and regionally appropriate cell types, and nondisruptive interspersion with host progenitors and their progeny. These human NSCs can be genetically engineered and are capable of expressing foreign transgenes in vivo. Supporting their gene therapy potential, secretory products from NSCs can correct a prototypical genetic metabolic defect in neurons and glia in vitro. The human NSCs can also replace specific deficient neuronal populations. Cryopreservable human NSCs may be propagated by both epigenetic and genetic means that are comparably safe and effective. By analogy to rodent NSCs, these observations may allow the development of NSC transplantation for a range of disorders.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1998 Nature Publishing Group | Privacy policy